MwanzoPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$ 1.26
Baada ya Saa za Kazi:(3.97%)-0.050
$ 1.21
Imefungwa: 16 Mac, 16:10:14 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 1.17
Bei za siku
$ 1.19 - $ 1.29
Bei za mwaka
$ 0.81 - $ 4.19
Thamani ya kampuni katika soko
14.64M USD
Wastani wa hisa zilizouzwa
7.43M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.06M | 53.41% |
Mapato halisi | -2.37M | -45.82% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.15 | — |
EBITDA | -2.53M | -51.31% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 21.03M | 290.77% |
Jumla ya mali | 21.49M | 274.47% |
Jumla ya dhima | 1.34M | 32.02% |
Jumla ya hisa | 20.15M | — |
hisa zilizosalia | 11.62M | — |
Uwiano wa bei na thamani | 0.68 | — |
Faida inayotokana na mali | -38.40% | — |
Faida inayotokana mtaji | -42.25% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.37M | -45.82% |
Pesa kutokana na shughuli | -2.08M | -51.64% |
Pesa kutokana na uwekezaji | 0.00 | -100.00% |
Pesa kutokana na ufadhili | 12.40M | 815.50% |
Mabadiliko halisi ya pesa taslimu | 10.33M | 129,175.00% |
Mtiririko huru wa pesa | -1.29M | -64.92% |
Kuhusu
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Ilianzishwa
2011
Tovuti
Wafanyakazi
6
